Investors Buy Envision Healthcare (EVHC) on Weakness

Investors purchased shares of Envision Healthcare (NYSE:EVHC) on weakness during trading on Tuesday. $46.01 million flowed into the stock on the tick-up and $17.63 million flowed out of the stock on the tick-down, for a money net flow of $28.38 million into the stock. Of all companies tracked, Envision Healthcare had the 30th highest net in-flow for the day. Envision Healthcare traded down ($0.07) for the day and closed at $44.39

A number of analysts have issued reports on the stock. Raymond James reiterated a “market perform” rating and issued a $51.00 target price on shares of Envision Healthcare in a research note on Tuesday, June 12th. Royal Bank of Canada cut shares of Envision Healthcare from an “outperform” rating to a “sector perform” rating in a research note on Tuesday, June 12th. Robert W. Baird lowered shares of Envision Healthcare from an “outperform” rating to a “neutral” rating in a research report on Monday, June 11th. Zacks Investment Research lowered shares of Envision Healthcare from a “buy” rating to a “hold” rating in a research report on Tuesday, May 1st. Finally, SunTrust Banks lowered shares of Envision Healthcare from a “buy” rating to a “hold” rating in a research report on Tuesday, June 12th. Two research analysts have rated the stock with a sell rating, twelve have given a hold rating and five have given a buy rating to the company’s stock. Envision Healthcare has an average rating of “Hold” and a consensus price target of $41.59.

The company has a debt-to-equity ratio of 0.65, a quick ratio of 2.25 and a current ratio of 2.27. The company has a market capitalization of $5.41 billion, a price-to-earnings ratio of 17.90, a price-to-earnings-growth ratio of 1.10 and a beta of 0.46.

Envision Healthcare (NYSE:EVHC) last posted its quarterly earnings results on Monday, May 7th. The company reported $0.71 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.64 by $0.07. Envision Healthcare had a net margin of 1.41% and a return on equity of 4.59%. The firm had revenue of $2.08 billion for the quarter, compared to the consensus estimate of $2.02 billion. During the same quarter in the previous year, the company earned $0.77 earnings per share. The business’s revenue was up 10.6% compared to the same quarter last year. equities research analysts expect that Envision Healthcare will post 3.41 earnings per share for the current fiscal year.

A number of institutional investors and hedge funds have recently bought and sold shares of EVHC. Maverick Capital Ltd. boosted its stake in Envision Healthcare by 30.7% during the fourth quarter. Maverick Capital Ltd. now owns 10,002,182 shares of the company’s stock worth $345,675,000 after buying an additional 2,349,648 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Envision Healthcare by 2,034.5% in the 1st quarter. JPMorgan Chase & Co. now owns 1,683,555 shares of the company’s stock valued at $64,698,000 after purchasing an additional 1,604,680 shares in the last quarter. Guggenheim Capital LLC boosted its stake in shares of Envision Healthcare by 140.4% in the 4th quarter. Guggenheim Capital LLC now owns 1,979,973 shares of the company’s stock valued at $68,429,000 after purchasing an additional 1,156,381 shares in the last quarter. Roystone Capital Management LP boosted its stake in shares of Envision Healthcare by 88.8% in the 1st quarter. Roystone Capital Management LP now owns 2,123,300 shares of the company’s stock valued at $81,598,000 after purchasing an additional 998,500 shares in the last quarter. Finally, Boston Partners boosted its stake in shares of Envision Healthcare by 362.0% in the 1st quarter. Boston Partners now owns 1,020,557 shares of the company’s stock valued at $39,220,000 after purchasing an additional 799,639 shares in the last quarter.

Envision Healthcare Company Profile

Envision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The company operates through two segments, Physician Services and Ambulatory Services. As of December 31, 2017, its physician-led services encompassed providers at approximately 1,800 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services.

Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply